Mice with a null mutation for TRPV4, or wild-type mice treated with a TRPV4 antagonist, showed elevated thermogenesis in adipose tissues and were protected from diet-induced obesity, adipose inflammation, and insulin resistance [50,51]. The gene discussed is TRPV4; the disease is obesity disorder.